We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
ETS1
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • ETS1
PROTEIN STRUCTURE
ANTIBODIES
AND
VALIDATION
Protein structures
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

ETS1
Synonyms ETS-1, EWSR2, FLJ10768
Gene descriptioni

Full gene name according to HGNC.

ETS proto-oncogene 1, transcription factor
Protein classi

Assigned HPA protein class(es) for the encoded protein(s).

Read more
Plasma proteins
RAS pathway related proteins
Transcription factors
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Protein evidence Evidence at protein level (all genes)
GENE INFORMATIONi

Gene information from Ensembl and Entrez, as well as links to available gene identifiers are displayed here. Information was retrieved from Ensembl if not indicated otherwise.

Chromosome 11
Cytoband q24.3
Chromosome location (bp) 128458761 - 128587558
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

6
Ensembl ENSG00000134954 (version 103.38)
Entrez gene 2113
HGNC HGNC:3488
UniProt P14921 (UniProt - Evidence at protein level)
neXtProt NX_P14921
Antibodypedia ETS1 antibodies


PROTEIN STRUCTUREi

The Structure section provides predicted structures from the Alphafold protein structure database and available experimental structures from Protein Data Bank (PDB).

In the Structure drop-down menu all experimental structures from PDB are available for selection and display. The structures are displayed using the NGL Viewer and can be zoomed-in and rotated either manually or by checking the Autorotate box. The Color scheme can be selected to show the residue index, chain name or confidence score (as B-factors and pLDDT score for experimental and predicted structures, respectively). The positions for available antigen sequences in the structure are shown if Antigens is turned to ON, and the Variants slider can be used to show the positions of clinical and population variants.https://github.com/nglviewer/ngl

Read more

Predicted


Description: Structure prediction from Alphafold project. Structure version 2

# Chains: 1      # Clinical variants: 0      # Population variants: 182

Antigens:

Off
On

Variants:

Off
Clinical
Population

Color scheme:

Confidence
Residue index
Chain name

Autorotate:

Off
On



PROTEIN BROWSERi

The protein browser displays the antigen location on the target protein(s) and the features of the target protein. The tabs at the top of the protein view section can be used to switch between the different splice variants to which an antigen has been mapped.

At the top of the view, the position of the antigen (identified by the corresponding HPA identifier) is shown as a green bar. A yellow triangle on the bar indicates a <100% sequence identity to the protein target.

Below the antigens, the maximum percent sequence identity of the protein to all other proteins from other human genes is displayed, using a sliding window of 10 aa residues (HsID 10) or 50 aa residues (HsID 50). The region with the lowest possible identity is always selected for antigen design, with a maximum identity of 60% allowed for designing a single-target antigen (read more).

The curve in blue displays the predicted antigenicity i.e. the tendency for different regions of the protein to generate an immune response, with peak regions being predicted to be more antigenic.The curve shows average values based on a sliding window approach using an in-house propensity scale. (read more).

If a signal peptide is predicted by a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius (turquoise) and/or transmembrane regions (orange) are predicted by MDM, these are displayed.

Low complexity regions are shown in yellow and InterPro regions in green. Common (purple) and unique (grey) regions between different splice variants of the gene are also displayed (read more), and at the bottom of the protein view is the protein scale.
ETS1-201
ETS1-202
ETS1-204
ETS1-207
ETS1-208
ETS1-209


PROTEIN INFORMATIONi

The protein information section displays alternative protein-coding transcripts (splice variants) encoded by this gene according to the Ensembl database.

The ENSP identifier links to the Ensembl website protein summary, while the ENST identifier links to the Ensembl website transcript summary for the selected splice variant. The data in the UniProt column can be expanded to show links to all matching UniProt identifiers for this protein.

The protein classes assigned to this protein are shown if expanding the data in the protein class column. Parent protein classes are in bold font and subclasses are listed under the parent class.

The Gene Ontology terms assigned to this protein are listed if expanding the Gene ontology column. The length of the protein (amino acid residues according to Ensembl), molecular mass (kDalton), predicted signal peptide (according to a majority of the signal peptide predictors SPOCTOPUS, SignalP 4.0, and Phobius) and the number of predicted transmembrane region(s) (according to MDM) are also reported.
Splice variant UniProt Protein class Gene ontology Length & mass Signal peptide
(predicted)
Transmembrane regions
(predicted)
ETS1-201
ENSP00000324578
ENST00000319397
P14921 [Direct mapping]
Protein C-ets-1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Helix-turn-helix domains
RAS pathway related proteins
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002376 [immune system process]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006366 [transcription by RNA polymerase II]
GO:0006955 [immune response]
GO:0008134 [transcription factor binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0010595 [positive regulation of endothelial cell migration]
GO:0010628 [positive regulation of gene expression]
GO:0030154 [cell differentiation]
GO:0030578 [PML body organization]
GO:0042025 [host cell nucleus]
GO:0042802 [identical protein binding]
GO:0043536 [positive regulation of blood vessel endothelial cell migration]
GO:0043565 [sequence-specific DNA binding]
GO:0045648 [positive regulation of erythrocyte differentiation]
GO:0045765 [regulation of angiogenesis]
GO:0045766 [positive regulation of angiogenesis]
GO:0045786 [negative regulation of cell cycle]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0048870 [cell motility]
GO:0050729 [positive regulation of inflammatory response]
GO:0051272 [positive regulation of cellular component movement]
GO:1902895 [positive regulation of pri-miRNA transcription by RNA polymerase II]
GO:1904996 [positive regulation of leukocyte adhesion to vascular endothelial cell]
Show all
441 aa
50.4 kDa
No 0
ETS1-202
ENSP00000376436
ENST00000392668
P14921 [Direct mapping]
Protein C-ets-1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Helix-turn-helix domains
RAS pathway related proteins
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0001666 [response to hypoxia]
GO:0002376 [immune system process]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006955 [immune response]
GO:0007565 [female pregnancy]
GO:0008134 [transcription factor binding]
GO:0008284 [positive regulation of cell population proliferation]
GO:0008285 [negative regulation of cell population proliferation]
GO:0009611 [response to wounding]
GO:0009612 [response to mechanical stimulus]
GO:0010595 [positive regulation of endothelial cell migration]
GO:0010628 [positive regulation of gene expression]
GO:0010715 [regulation of extracellular matrix disassembly]
GO:0021854 [hypothalamus development]
GO:0021983 [pituitary gland development]
GO:0030154 [cell differentiation]
GO:0030335 [positive regulation of cell migration]
GO:0030578 [PML body organization]
GO:0032355 [response to estradiol]
GO:0034616 [response to laminar fluid shear stress]
GO:0035035 [histone acetyltransferase binding]
GO:0042025 [host cell nucleus]
GO:0042802 [identical protein binding]
GO:0043536 [positive regulation of blood vessel endothelial cell migration]
GO:0043565 [sequence-specific DNA binding]
GO:0044849 [estrous cycle]
GO:0045648 [positive regulation of erythrocyte differentiation]
GO:0045765 [regulation of angiogenesis]
GO:0045766 [positive regulation of angiogenesis]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0048870 [cell motility]
GO:0050729 [positive regulation of inflammatory response]
GO:0051272 [positive regulation of cellular component movement]
GO:0060055 [angiogenesis involved in wound healing]
GO:0070301 [cellular response to hydrogen peroxide]
GO:0070555 [response to interleukin-1]
GO:1902895 [positive regulation of pri-miRNA transcription by RNA polymerase II]
GO:1904996 [positive regulation of leukocyte adhesion to vascular endothelial cell]
Show all
485 aa
55.4 kDa
No 0
ETS1-204
ENSP00000433500
ENST00000526145
P14921 [Direct mapping]
Protein C-ets-1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Helix-turn-helix domains
RAS pathway related proteins
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002376 [immune system process]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006955 [immune response]
GO:0008134 [transcription factor binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0010595 [positive regulation of endothelial cell migration]
GO:0010628 [positive regulation of gene expression]
GO:0030154 [cell differentiation]
GO:0030578 [PML body organization]
GO:0042025 [host cell nucleus]
GO:0042802 [identical protein binding]
GO:0042981 [regulation of apoptotic process]
GO:0043536 [positive regulation of blood vessel endothelial cell migration]
GO:0043565 [sequence-specific DNA binding]
GO:0045648 [positive regulation of erythrocyte differentiation]
GO:0045765 [regulation of angiogenesis]
GO:0045766 [positive regulation of angiogenesis]
GO:0045786 [negative regulation of cell cycle]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0046677 [response to antibiotic]
GO:0048870 [cell motility]
GO:0050729 [positive regulation of inflammatory response]
GO:0051272 [positive regulation of cellular component movement]
GO:1902895 [positive regulation of pri-miRNA transcription by RNA polymerase II]
GO:1904996 [positive regulation of leukocyte adhesion to vascular endothelial cell]
Show all
354 aa
40.8 kDa
No 0
ETS1-207
ENSP00000435666
ENST00000531611
P14921 [Direct mapping]
Protein C-ets-1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Helix-turn-helix domains
RAS pathway related proteins
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002376 [immune system process]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006955 [immune response]
GO:0008134 [transcription factor binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0010595 [positive regulation of endothelial cell migration]
GO:0010628 [positive regulation of gene expression]
GO:0030154 [cell differentiation]
GO:0030578 [PML body organization]
GO:0042025 [host cell nucleus]
GO:0042802 [identical protein binding]
GO:0043536 [positive regulation of blood vessel endothelial cell migration]
GO:0043565 [sequence-specific DNA binding]
GO:0045648 [positive regulation of erythrocyte differentiation]
GO:0045765 [regulation of angiogenesis]
GO:0045766 [positive regulation of angiogenesis]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0048870 [cell motility]
GO:0050729 [positive regulation of inflammatory response]
GO:0051272 [positive regulation of cellular component movement]
GO:1902895 [positive regulation of pri-miRNA transcription by RNA polymerase II]
GO:1904996 [positive regulation of leukocyte adhesion to vascular endothelial cell]
Show all
272 aa
30.9 kDa
No 0
ETS1-208
ENSP00000441430
ENST00000535549
P14921 [Direct mapping]
Protein C-ets-1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
Plasma proteins
Transcription factors
   Helix-turn-helix domains
RAS pathway related proteins
Mapped to neXtProt
   neXtProt - Evidence at protein level
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000785 [chromatin]
GO:0000978 [RNA polymerase II cis-regulatory region sequence-specific DNA binding]
GO:0000981 [DNA-binding transcription factor activity, RNA polymerase II-specific]
GO:0001228 [DNA-binding transcription activator activity, RNA polymerase II-specific]
GO:0002376 [immune system process]
GO:0003677 [DNA binding]
GO:0003700 [DNA-binding transcription factor activity]
GO:0005515 [protein binding]
GO:0005634 [nucleus]
GO:0005654 [nucleoplasm]
GO:0005737 [cytoplasm]
GO:0006355 [regulation of transcription, DNA-templated]
GO:0006357 [regulation of transcription by RNA polymerase II]
GO:0006955 [immune response]
GO:0008134 [transcription factor binding]
GO:0008285 [negative regulation of cell population proliferation]
GO:0010595 [positive regulation of endothelial cell migration]
GO:0010628 [positive regulation of gene expression]
GO:0030154 [cell differentiation]
GO:0030578 [PML body organization]
GO:0042802 [identical protein binding]
GO:0043536 [positive regulation of blood vessel endothelial cell migration]
GO:0043565 [sequence-specific DNA binding]
GO:0045648 [positive regulation of erythrocyte differentiation]
GO:0045765 [regulation of angiogenesis]
GO:0045766 [positive regulation of angiogenesis]
GO:0045893 [positive regulation of transcription, DNA-templated]
GO:0045944 [positive regulation of transcription by RNA polymerase II]
GO:0048870 [cell motility]
GO:0050729 [positive regulation of inflammatory response]
GO:0051272 [positive regulation of cellular component movement]
GO:1902895 [positive regulation of pri-miRNA transcription by RNA polymerase II]
GO:1904996 [positive regulation of leukocyte adhesion to vascular endothelial cell]
Show all
225 aa
25.7 kDa
No 0
ETS1-209
ENSP00000476649
ENST00000608978
V9GYD6 [Direct mapping]
Protein C-ets-1
Show all
Predicted intracellular proteins
   Intracellular proteins predicted by MDM and MDSEC
RAS pathway related proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0042025 [host cell nucleus]
GO:0043565 [sequence-specific DNA binding]
Show all
46 aa
5.2 kDa
No 0

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.